Bessemer Group Inc Glaukos Corp Transaction History
Bessemer Group Inc
- $61.3 Billion
- Q4 2024
A detailed history of Bessemer Group Inc transactions in Glaukos Corp stock. As of the latest transaction made, Bessemer Group Inc holds 118 shares of GKOS stock, worth $11,874. This represents 0.0% of its overall portfolio holdings.
Number of Shares
118
Previous 54
118.52%
Holding current value
$11,874
Previous $7,000
157.14%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding GKOS
# of Institutions
355Shares Held
50.1MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$809 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$601 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.16MShares$217 Million0.06% of portfolio
-
State Street Corp Boston, MA2.06MShares$208 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$194 Million0.08% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.79B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...